JP2016513523A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513523A5
JP2016513523A5 JP2015562517A JP2015562517A JP2016513523A5 JP 2016513523 A5 JP2016513523 A5 JP 2016513523A5 JP 2015562517 A JP2015562517 A JP 2015562517A JP 2015562517 A JP2015562517 A JP 2015562517A JP 2016513523 A5 JP2016513523 A5 JP 2016513523A5
Authority
JP
Japan
Prior art keywords
solution
item
bile
seq
target area
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015562517A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016513523A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/059765 external-priority patent/WO2014141160A1/en
Publication of JP2016513523A publication Critical patent/JP2016513523A/ja
Publication of JP2016513523A5 publication Critical patent/JP2016513523A5/ja
Pending legal-status Critical Current

Links

JP2015562517A 2013-03-14 2014-03-13 胆汁漏の処置 Pending JP2016513523A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361784496P 2013-03-14 2013-03-14
US61/784,496 2013-03-14
PCT/IB2014/059765 WO2014141160A1 (en) 2013-03-14 2014-03-13 Treatment for bile leakage

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018079164A Division JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Publications (2)

Publication Number Publication Date
JP2016513523A JP2016513523A (ja) 2016-05-16
JP2016513523A5 true JP2016513523A5 (enExample) 2017-04-13

Family

ID=50397217

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015562517A Pending JP2016513523A (ja) 2013-03-14 2014-03-13 胆汁漏の処置
JP2018079164A Pending JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018079164A Pending JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Country Status (5)

Country Link
US (1) US20160030628A1 (enExample)
EP (1) EP2968654A1 (enExample)
JP (2) JP2016513523A (enExample)
HK (1) HK1220145A1 (enExample)
WO (1) WO2014141160A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345433B1 (en) 2008-10-06 2017-03-01 3-D Matrix, Ltd. Tissue plug
JP6389170B2 (ja) 2012-07-06 2018-09-12 スリーディー マトリックス， エルティーディー３−Ｄ Ｍａｔｒｉｘ， Ｌｔｄ． ペプチド溶液のためのフィル−フィニッシュ過程
CA2939696C (en) 2014-03-10 2023-01-10 3-D Matrix, Ltd. Self-assembling peptide compositions
JP6684719B2 (ja) 2014-03-10 2020-04-22 株式会社スリー・ディー・マトリックス ペプチド組成物の滅菌および濾過
ES2712608T3 (es) 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
US20210023257A1 (en) * 2016-03-18 2021-01-28 3-D Matrix, Ltd. Cerebrospinal fluid leakage occlusion
US20190091376A1 (en) * 2016-03-18 2019-03-28 3-D Matrix, Ltd. Preventing Biological Tissue Adhesion
MX2018011120A (es) * 2016-03-18 2019-03-28 3 D Matrix Ltd Oclusion de fistula pancreatica.
WO2021202577A1 (en) 2020-03-31 2021-10-07 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4023240A1 (en) * 2004-07-06 2022-07-06 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US9327010B2 (en) * 2005-04-25 2016-05-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
EP2345433B1 (en) * 2008-10-06 2017-03-01 3-D Matrix, Ltd. Tissue plug
US8962784B2 (en) * 2008-12-19 2015-02-24 Ethicon, Inc. Isocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant

Similar Documents

Publication Publication Date Title
JP2016513523A5 (enExample)
JP2016515113A5 (enExample)
Tyler et al. Nanomedicine for treating spinal cord injury
JP6554121B2 (ja) 気管支閉鎖剤としての自己組織化ペプチド
JP2017513927A5 (enExample)
Teng et al. An animal model of glomerular light-chain-associated amyloidogenesis depicts the crucial role of lysosomes
CA2703234C (en) An inhalable dry powder formulation comprising glp-1 for use by pulmonary inhalation
JP2017519568A5 (enExample)
JP2017513928A5 (enExample)
US20170072008A1 (en) Autoassembling peptides for the treatment of pulmonary bulla
JP2018130552A (ja) 胆汁漏の処置
Yao et al. Dual Dynamic Crosslinked Hydrogel Patch Embodied with Anti‐Bacterial and Macrophage Regulatory Properties for Synergistic Prevention of Peritendinous Adhesion
JP2016501066A5 (enExample)
JP2015515462A5 (enExample)
US20170173105A1 (en) Autoassembling peptides for the treatment of pulmonary leakage
EP4309722A3 (en) Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
JP2019206544A (ja) 次亜塩素酸ナトリウムを含む抗炎症溶液
JP2019508175A (ja) 膵液瘻の閉鎖
US20150231170A1 (en) Wound healing compositions comprising microspheres
RU2015148636A (ru) Модуляция активности гепарин-связывающего эпидермального фактора роста для заживления барабанной перепонки
JP5822724B2 (ja) 疼痛、炎症、ニューロンもしくは血管損傷に対する生物学的マーカーおよび治療への応答、ならびにその使用方法
RU2018100879A (ru) Быстродействующая распадающаяся в ротовой полости пленка для проведения местного обезболивания
JP2019518569A5 (enExample)
ME02644B (me) Novi preparati alfentanila za tretman akutnog bola
WO2017066444A1 (en) Treatment of learning disabilities and other neurological disorders with sk channel inhibitor(s)